3D DL Ozteo in the Detection of Osseous Changes in Patients with Inflammatory Arthritis

NARecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 5, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

December 31, 2026

Conditions
Inflammatory Arthritis
Interventions
DEVICE

oZTEo

An FDA approved MRI pulse sequence, oZTEo, will be added to a standard of care MRI examination. The oZTEo pulse sequence will be anonymized and sent to GE Healthcare for the application of a deep learning algorithm, 3D DL.

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

Mayo Clinic

OTHER